| RS1777239433 |
FIG4
|
Health Risk |
Likely pathogenic |
Cerebral hypomyelination, Cerebral hypomyelination |
| RS1777242231 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1777270779 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1777296419 |
FIG4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS1777299176 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1777305165 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 5 |
| RS1777306901 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS1777307832 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1777321509 |
RARS2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1777360602 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1777387465 |
DNAH5
|
Health Risk |
Pathogenic |
DNAH5-related disorder, DNAH5-related disorder |
| RS1777434181 |
TNXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS1777499541 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS17775170 |
SLC9A2
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS17776256 |
TMEM260
|
Health Risk |
Likely pathogenic |
— |
| RS1777638564 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1777654334 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 1, Joubert syndrome 1 |
| RS1777663813 |
CPLANE1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1777777927 |
PLG
|
Health Risk |
Pathogenic |
Plasminogen deficiency, type I |
| RS1777825845 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS1777874560 |
MYO6
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal dominant nonsyndromic hearing loss 22 |
| RS1777909965 |
FIG4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1777959239 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1777959964 |
TERC
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1777963643 |
LOC110806306;TERC
|
Health Risk |
Likely pathogenic |
— |
| RS1777963668 |
TERC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1777964165 |
TERC
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 1 |
| RS1777983774 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1778000792 |
TDP2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 23 |
| RS1778006795 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS1778054006 |
MYO6
|
Health Risk |
Likely pathogenic |
MYO6-related disorder, MYO6-related disorder |
| RS1778083045 |
FIG4
|
Health Risk |
Pathogenic |
— |
| RS1778129968 |
FIG4
|
Health Risk |
Pathogenic |
— |
| RS1778144240 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1778167481 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1778167658 |
FIG4
|
Health Risk |
Likely pathogenic |
Severe global developmental delay, Penile hypospadias |
| RS1778232291 |
TNXB
|
Health Risk |
Likely pathogenic |
— |
| RS1778238126 |
RSPH3
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS1778273068 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1778283565 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1778379197 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1778386695 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1778446608 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1778646780 |
TNXB
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS1778714650 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1778747154 |
MAK
|
Health Risk |
Likely pathogenic |
— |
| RS1778756196 |
ARID1B;LOC115308161;LOC129997523
|
Health Risk |
Pathogenic |
— |
| RS1778783139 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS1778789800 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1778791602 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1778794132 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS1778794887 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1778806259 |
TRDN
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1778806787 |
ARID1B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Hirsutism |
| RS1778824262 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1778831733 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Neurodevelopmental disorder with cerebellar atrophy and with or without seizures |
| RS1778838576 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1778877596 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1778885211 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1778893542 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1778926656 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1778944605 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1778945620 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, ARID1B-related disorder |
| RS1778960981 |
BRAT1
|
Health Risk |
Likely pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1778980785 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neurodevelopmental disorder with cerebellar atrophy and with or without seizures |
| RS1778981404 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS1778987915 |
BRAT1
|
Health Risk |
Likely pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1778991422 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1778991763 |
ARID1B
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1778992944 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 3, Joubert syndrome 3 |
| RS1779001773 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1779001902 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1779002290 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1779004027 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome 1, ARID1B-related BAFopathy |
| RS1779009539 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1779015991 |
ARID1B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1779020146 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS1779022643 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1779031164 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS1779032666 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Inborn genetic diseases |
| RS1779035528 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome type 6, Joubert syndrome 17 |
| RS1779043930 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1779064401 |
COL10A1
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS1779066083 |
PLN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS1779066131 |
COL10A1
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS1779066482 |
COL10A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal chondrodysplasia, Schmid type |
| RS1779067300 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS1779072006 |
PLN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1P, Cardiovascular phenotype |
| RS1779072705 |
COL10A1
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS1779073142 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS1779077264 |
COL10A1
|
Health Risk |
Pathogenic |
— |
| RS1779105755 |
BRAT1
|
Health Risk |
Likely pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1779135449 |
MPC1
|
Health Risk |
Likely pathogenic |
Mitochondrial pyruvate carrier deficiency, Mitochondrial pyruvate carrier deficiency |
| RS1779262959 |
IFNGR1
|
Health Risk |
Likely pathogenic |
Disseminated atypical mycobacterial infection, Disseminated atypical mycobacterial infection |
| RS1779318396 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1779323338 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1779368057 |
BRAT1
|
Health Risk |
Pathogenic |
— |
| RS1779402696 |
TRDN
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 5, Catecholaminergic polymorphic ventricular tachycardia 5 |
| RS1779406142 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1779423047 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |